Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

Clinical trial NCT04071405 · COMPLETED

Trial details

NCT number: NCT04071405
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis

Start date: 2020-05-12
Primary completion: 2022-09-26
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.